The DOI matches its Crossref record.
Loss of FilaminC (FLNc) Results in Severe Defects in Myogenesis and Myotube Structure
Open accessAbstract
FilaminC (FLNc) is the muscle-specific member of a family of actin binding proteins. Although it interacts with many proteins involved in muscular dystrophies, its unique role in muscle is poorly understood. To address this, two models were developed. First, FLNc expression was stably reduced in C2C12 myoblasts by RNA interference. While these cells start differentiation normally, they display defects in differentiation and fusion ability and ultimately form multinucleated "myoballs" rather than maintain elongated morphology. Second, a mouse model carrying a deletion of last 8 exons of Flnc was developed. FLNc-deficient mice die shortly after birth, due to respiratory failure, and have severely reduced birth weights, with fewer muscle fibers and primary myotubes, indicating defects in primary myogenesis. They exhibit variation in fiber size, fibers with centrally located nuclei, and some rounded fibers resembling the in vitro phenotype. The similarity of the phenotype of FLNc-deficient mice to the filamin-interacting TRIO null mice was further confirmed by comparing FLNc-deficient C2C12 cells to TRIO-deficient cells. These data provide the first evidence that FLNc has a crucial role in muscle development and maintenance of muscle structural integrity and suggest the presence of a TRIO-FLNc-dependent pathway in maintaining proper myotube structure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Dilated Cardiomyopathy: Genetic Determinants and Mechanisms
McNally, E. M., & Mestroni, L. (2017) · Circulation Research · doi:10.1161/circresaha.116.309396 · Cited by 786
“Filamin C interacts with the dystrophin complex, and deletion of Flnc from the mouse leads to skeletal myopathy.(131,132) In humans, truncating mutations lead to cardiomyopathy that is associated with a high rate of ventricular arrhythmias and SCD, suggesting that filamin C has a role in the cardiac conduction system…”
Satellite Cells and Skeletal Muscle Regeneration
Dumont, N. A., Bentzinger, C. F., Sincennes, M., & Rudnicki, M. A. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c140068 · Cited by 719
“In vitro , knockdown of FilaminC in differentiating myoblasts results in formation of small and round myotubes with limited numbers of nuclei (78).”
Myoblast fusion: lessons from flies and mice
Abmayr, S. M., & Pavlath, G. K. (2012) · Development · doi:10.1242/dev.068353 · Cited by 529
The filamins: Organizers of cell structure and function
Nakamura, F., Stossel, T. P., & Hartwig, J. H. (2011) · Cell Adhesion & Migration · doi:10.4161/cam.5.2.14401 · Cited by 451
Filamins in cell signaling, transcription and organ development
Zhou, A.-X., Hartwig, J. H., & Akyürek, L. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.12.001 · Cited by 319
Delling, F. N., & Vasan, R. S. (2014) · Circulation · doi:10.1161/circulationaha.113.006702 · Cited by 315
Filamins in Mechanosensing and Signaling
Razinia, Z., Mäkelä, T., Ylänne, J., & Calderwood, D. A. (2012) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-050511-102252 · Cited by 252
Minor hypertrophic cardiomyopathy genes, major insights into the genetics of cardiomyopathies
Walsh, R., Offerhaus, J. A., Tadros, R., & Bezzina, C. R. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00608-2 · Cited by 115
Cullin-3–dependent deregulation of ACTN1 represents a pathogenic mechanism in nemaline myopathy
Blondelle, J., Tallapaka, K., Seto, J. T., Ghassemian, M., Clark, M., Laitila, J. M., Bournazos, A., Singer, J. D., & Lange, S. (2019) · JCI Insight · doi:10.1172/jci.insight.125665 · Cited by 26
Metadata
- Authors
- Dalkilic, I., Schienda, J., Thompson, T. G., & Kunkel, L. M.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2006-09-01
- Volume
- 26
- Issue
- 17
- Pages
- 6522-6534
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2168322305
- Cited by
- 188
- References
- 0
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.